Testing effectiveness (Phase 2)Study completedNCT03861481
What this trial is testing
Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Who this might be right for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
UCB Biopharma S.P.R.L. 34